Candriam S.C.A. Heron Therapeutics, Inc. Transaction History

Candriam S.C.A.

$15.6 Billion
Q1 2025

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$4.63 - $9.94 $249,987 - $536,690	-53,993 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$8.35 - $12.6 $942,907 - $1.42 Million	-112,923 Reduced 67.65%	53,993 $493,000
Q3 2021 Nov 09, 2021	SELL	$10.13 - $15.0 $5.99 Million - $8.87 Million	-591,654 Reduced 78.0%	166,916 $1.78 Million
Q2 2021 Jul 20, 2021	SELL	$13.27 - $18.48 $7.05 Million - $9.82 Million	-531,203 Reduced 41.19%	758,570 $11.8 Million
Q4 2020 Jan 22, 2021	SELL	$14.61 - $22.14 $426,597 - $646,465	-29,199 Reduced 2.21%	1,289,773 $27.3 Million
Q3 2020 Oct 19, 2020	BUY	$13.67 - $17.77 $546,800 - $710,800	40,000 Added 3.13%	1,318,972 $19.5 Million
Q2 2020 Jul 23, 2020	BUY	$10.89 - $21.47 $6.3 Million - $12.4 Million	578,462 Added 82.58%	1,278,972 $18.8 Million
Q4 2019 Jan 21, 2020	SELL	$17.42 - $26.61 $5.33 Million - $8.15 Million	-306,090 Reduced 30.41%	700,510 $16,000
Q3 2019 Oct 21, 2019	BUY	$16.36 - $21.39 $5.53 Million - $7.23 Million	338,000 Added 50.55%	1,006,600 $19,000
Q2 2019 Aug 01, 2019	BUY	$16.93 - $26.22 $1.35 Million - $2.1 Million	80,000 Added 13.59%	668,600 $12.4 Million
Q1 2019 May 02, 2019	BUY	$23.15 - $28.34 $2.89 Million - $3.54 Million	125,000 Added 26.96%	588,600 $14.4 Million
Q4 2018 Feb 14, 2019	BUY	$22.03 - $32.01 $2.67 Million - $3.88 Million	121,200 Added 35.4%	463,600 $12 Million
Q3 2018 Nov 07, 2018	BUY	$30.0 - $40.85 $8.2 Million - $11.2 Million	273,400 Added 396.23%	342,400 $10.8 Million
Q2 2018 Aug 14, 2018	BUY	$26.4 - $42.0 $1.82 Million - $2.9 Million	69,000 New	69,000 $2.68 Million

Others Institutions Holding HRTX

# of Institutions

182

Shares Held

125M

Call Options Held

847K

Put Options Held

47.7K

Rubric Capital Management LP New York, NY

26.7M
Shares

$51.8 Million
1.68% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$16.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

8.23M
Shares

$16 Million
0.0% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

7.85M
Shares

$15.2 Million
0.03% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$13.6 Million
26.51% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $230M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account